-transparent.png){kind=logo}
Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment.
Related Publications
N H Mulder, and
D T Sleijfer, and
E G de Vries, and
H Schraffordt Koops, and
P H Willemse
August 1991,
Investigational new drugs,
N H Mulder, and
D T Sleijfer, and
E G de Vries, and
H Schraffordt Koops, and
P H Willemse
January 1980,
Cancer treatment reports,
N H Mulder, and
D T Sleijfer, and
E G de Vries, and
H Schraffordt Koops, and
P H Willemse
January 1980,
Cancer treatment reports,
N H Mulder, and
D T Sleijfer, and
E G de Vries, and
H Schraffordt Koops, and
P H Willemse
June 2002,
American journal of clinical oncology,
N H Mulder, and
D T Sleijfer, and
E G de Vries, and
H Schraffordt Koops, and
P H Willemse
September 1987,
Cancer treatment reports,
N H Mulder, and
D T Sleijfer, and
E G de Vries, and
H Schraffordt Koops, and
P H Willemse
January 1994,
European journal of cancer (Oxford, England : 1990),
N H Mulder, and
D T Sleijfer, and
E G de Vries, and
H Schraffordt Koops, and
P H Willemse
December 1985,
Cancer treatment reports,
N H Mulder, and
D T Sleijfer, and
E G de Vries, and
H Schraffordt Koops, and
P H Willemse
April 1989,
European journal of cancer & clinical oncology,
N H Mulder, and
D T Sleijfer, and
E G de Vries, and
H Schraffordt Koops, and
P H Willemse
January 1995,
Tumori,
N H Mulder, and
D T Sleijfer, and
E G de Vries, and
H Schraffordt Koops, and
P H Willemse
February 1987,
Cancer treatment reports,
